"TO THRIVE AS A FIELD, DIGITAL MEDICINE REQUIRES AN UNPRECEDENTED LEVEL OF INTERDISCIPLINARY COLLABORATION. FROM REGULATORS TO WHITE-HAT HACKERS, ETHICISTS TO ENGINEERS, AND CLINICIANS TO CITIZEN SCIENTISTS, NEW COOPERATIVE NETWORKS MUST EMERGE TO ENSURE THAT DIGITAL MEDICINE REALIZES ITS FULL POTENTIAL TO IMPROVE HUMAN HEALTH." (DIGITAL MEDICINE SOCIETY)
Returning to Pfizer in Cambridge, the Digital Implementation Forum focuses on ways for life sciences to take advantage of new opportunities within digital health and digital measurement; as well as how these new data can supplement existing collection strategies to drive research forward. Be a part of the movement to get these validated digital measures and digital health tools (DHTs) into the hands of patients, their physicians and caregivers.

Join 30+ speakers, 150 senior-level pharma, clinical trials, technology and digital health executives this November 13, 2024 at Pfizer in Cambridge to learn, network, develop and improve the way digital health measurement tools are being created, standardized, scaled and deployed in life sciences to improve data quality, improve patient experience & accelerate drug development.
Location
Pfizer Innovation Research (PfIRe Lab)
1 Portland St
Cambridge, MA 02139
Date & Time
November 13, 2024
9:00am - 5:30pm
JUST RELEASED! 2024 CORE THEMES!

1. What is the Value Proposition for Digital Tools to Stakeholders in Clinical Research: Patients, Payers, HCPs, Sites & Regulators

       • From the perspective of patients, what sort of value can be delivered with the integration of digital tools; and how much measurement is too much?
       • From the perspective of HCPs, how digital can improve the patient care scenario and without being overly burdensome
       • From a payer perspective, how can this be integrated into your care optimization pathway to improve outcomes

       • How to streamline the Deployment of Digital Tools in Clinical Research to be as frictionless as possible for clinical research sites
       • Site Partners talk about improving the process from the operations standpoint

 
2. "How To" Session


• How to engage with patients directly about measures that matter to them
• How to engage with sites to determine existing workflows and best operationalize deployment of additional digital resources
• How to convince project teams that it is a good idea to implement more digital into study protocols

3. Operationalizing Digital Measurement Tools & Closing Discussions

• The latest advances in Digital Endpoints and the State of the Space
2024 Speakers and Advisors
Carrie Northcott
Sr. Director, Head of Digital Sciences
(Conference Chair)
PFIZER
Tim McCarthy
VP, Head of Digital Sciences & Translational Imaging
PFIZER
Xuemei Cai
Sr. Director, Head of Clinical Research
PFIZER

Edward Cox
Head & General Manager of Digital Health and Medicines (DHM)
PFIZER
Joseph DiMasi
Director of Economic Analysis, Center for the Study of Drug Development
TUFTS UNIVERSITY
Tarik Yardibi
Director, Sensing & Measurement
TAKEDA
Samantha Reyes
Patient Engagement Lead
SANOFI
Abigail Newell
Director of Research
CANCER SUPPORT COMMUNITY
Ann-Marie Laronde-Richard
Director and Patient Engagement Lead
PFIZER
Caroline Currie
Head of Product, Digital Biomarkers
VERILY
Richard Thomas
CEO
ACTIVINSIGHTS
Federico Parisi
Principal Data Scientist, Data Science & Digital Health
J&J INNOVATIVE MEDICINE
Noman Ashraf
Principal Data Scientist, Data Science & Digital Health
J&J INNOVATIVE MEDICINE
Matteo Lai
CEO
EMPATICA
Brett Hauber
Senior Director, Patient Preference Expert
PFIZER
Sachin Shah
Digital Biomarker Lead
GSK
Martha Azer
Associate Director, Regulatory Policy NA
J&J INNOVATIVE MEDICINE
Andrew Kaseman
Implementation Manager, Digital Strategy
TAKEDA
Eric Mangin
Director, Digital Clinical Measures
MERCK
Rinol Alaj
Head of Digital Health Technologies
REGENERON
Isik Karahanoglu
Director, Early Clinical Development, Digital Sciences
PFIZER
Jeremy Wyatt
CEO
ACTIGRAPH
Charmaine Demanuele
Executive Director, Head of Quantitative Sciences
PFIZER
Gül Erdemli
Global Program Regulatory Director
NOVARTIS
Daniel Kalanovic
VP, Head of Medical Digital Health
PFIZER
Agenda: November 13, 2024
8:00 AM

Registration, Coffee and Conversation
Conference registration open with continental breakfast and coffee served
9:00 AM

Opening Remarks from Conference Chair

Carrie Northcott, Head of Digital Sciences, Pfizer
9:10 AM

What is the Value Proposition for Digital Tools to Stakeholders in Clinical Research: Patients, Payers, HCPs, Sites & Regulators
9:10 AM

The Journey to Measuring Physical Activity in Patients with Cachexia

Isik Karahanoglu, Director, Early Clinical Development, Digital Sciences & Translational Imaging Quantitative Sciences, Pfizer
9:30 AM

Continuing the Regulatory Acceptance Journey for Successful use of DHTs

Martha Azer, Associate Director, Regulatory Policy NA, Johnson & Johnson Innovative Medicine
9:45 AM

Presentation TBA

Matteo Lai, CEO, Empatica
10:05 AM

PANEL DISCUSSION: What is the Value Proposition for Digital Tools to Stakeholders in Clinical Research: Patients, Payers, HCPs, Regulators
 
Tim McCarthy, VP, Head of Digital Sciences & Translational Imaging, Pfizer
Rinol Alaj, Head of Digital Health Technologies, Regeneron
Gül Erdemli, Global Program Regulatory Director, Novartis
Daniel Kalanovic, VP, Head of Medical Digital Health, Pfizer

Led by Xuemei Cai, Sr. Director, Head of Clinical Research, Pfizer
10:30 AM

NETWORKING COFFEE BREAK

11:00 aM

Beyond Wearables: Digital Implementation in Clinical Settings

Andrew Kaseman, Implementation Manager, Digital Strategy, Takeda
11:20 aM

Presentation TBA

Richard Thomas, CEO, Activinsights
11:40 aM

Patient’s Compliance to Wearing an Actigraphy Device and its Effect on the Estimation of Actigraphy-derived Measures of Exercise Capacity in Pulmonary Hypertension

Federico Parisi, Principal Data Scientist, Data Science & Digital Health, Johnson & Johnson Innovative Medicine
Noman Ashraf, Principal Data Scientist, Data Science & Digital Health, Johnson & Johnson Innovative Medicine
12:00 PM

PANEL DISCUSSION: How to streamline the Deployment & Implementation of Digital Tools in Clinical Research to be as Frictionless as Possible  

Erin Mangin, Director, Digital Clinical Measures, Merck
Andrew Kaseman, Implementation Manager, Digital Strategy, Takeda
Speaker TBA, Analog Devices

Led by Charmaine Demanuele, Executive Director, Head of Quantitative Sciences, Pfizer

12:25 PM

NETWORKING LUNCHEON

1:15 PM

"How To" Session

• How to engage with patients directly about measures that matter to them
• How to engage with sites to determine existing workflows and best operationalize deployment of additional digital resources
• How to convince project teams that it is a good idea to implement more digital into study protocols
1:15 PM

Possibilities and Promise of Leveraging Digital Measures To Benefit all Stakeholders in Clinical Research

Edward Cox, Head & General Manager of Digital Health and Medicines (DHM), Pfizer
1:35 PM

Assessing the Net Financial Benefits of Employing Digital Endpoints in Clinical Trials

Joe DiMasi, Director of Economic Analysis, Tufts University Center for the Study of Drug Development
1:50 PM

Oncology Patient Advocacy and Patient Preference

Abigail Newell, Director, Research, Cancer Support Community
Brett Hauber, Sr Director, Patient Preference Expert, Pfizer

2:10 PM

How to Engage with Patients Directly about Measures that Matter to Them

Samantha Reyes, Patient Engagement Lead, Sanofi
2:25 PM

PANEL DISCUSSION: The Imperative of Patient Engagement in driving DHTs into Wider Use as Clinical Tools / Digital Therapeutics

Abigail Newell, Director, Research, Cancer Support Community
Samantha Reyes, Patient Engagement Lead, Sanofi
Ann-Marie Laronde-Richard, Director and Patient Engagement Lead, Pfizer 

Moderated by Carrie Northcott, Head of Digital Sciences, Pfizer
2:45 PM

NETWORKING COFFEE AND REFRESHMENT BREAK

Located in Foyer and Exhibition Area

3:05 PM

Operationalizing Digital Measurement Tools & Closing Discussions 
3:05 PM

Developing Digital Endpoints that Matter for PD Trials & Lessons Learned from Failure

Caroline Currie, Head of Product, Digital Biomarkers, Verily
3:25 PM

Presentation TBA

Jeremy Wyatt, CEO, Actigraph
3:45 PM

CONCLUDING PANEL DISCUSSION: Operationalizing Digital Measurement Tools & Closing Discussions 

Tarik Yardibi, Director, Sensing & Measurement, Takeda
Sachin Shah, Digital Biomarker Lead, GSK
Additional panelists TBA

Moderated by Mar Santamaria, Clinician, Sr. Director, Pfizer
4:10 - 5:10 PM

NETWORKING RECEPTION


HOST SPONSOR
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
SILVER SPONSOR
EXHIBITOR

Interested in Sponsorship & Exhibition Opportunities?
Location
Pfizer Innovation Research (PfIRe) Lab 
Cambridge, MA
The PfIRe Lab is a highly instrumented clinical research facility located in Cambridge, Massachusetts. Here, researchers use cutting-edge wearable and environmental sensors to develop and validate novel, patient-centric clinical endpoints, thereby potentially enabling a better understanding of a patient’s disease state and response to therapy.

Pfizer’s Digital Medicine & Translational Imaging Team recently unveiled this industry-leading facility in Cambridge, Massachusetts, designed to rapidly evaluate and validate novel technologies for potential use in clinical trials. In the PfIRe Lab, a multidisciplinary team of clinicians and researchers utilize state-of-the-art motion capture technologies, coupled with environmental and wearable sensors to develop new patient-centric clinical trial endpoints, enabling measures of physical function and activity outside of the traditional hospital and clinical settings.
 Join us at the 
Digital Implementation Summit 2024!
The Premiere Event Connecting Clinical Trials to Clinical Use for Life Sciences

Processing Registration...